Cepheid reagents and supplies, hhcc
Ended Awarded Last action
- Contract number
- 75H71223F28005
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $187,000
Award facts
- Opportunity
-
- Cepheid Reagent Test Cartridges and Consumables - Phoenix Area Wide Special Notice · PHXSS23002 · Posted Oct 21, 2022
- Contract value 100% obligated
- $187,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$85,000 | |
| Other Administrative Action | $0 | |
| Original award | $272,000 |
About this award
The Indian Health Service awarded a $187,000 firm fixed-price Blanket Purchase Agreement (BPA) call to Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, for reagents and supplies. The contract, which was ultimately completed and closed out on February 7, 2024, approximately one year after its February 8, 2023 award date, involved no set-aside designation. This award represents a continuation of Cepheid's ongoing relationship with federal healthcare agencies, specifically supporting IHS's diagnostic testing capabilities through the company's core product offerings of molecular diagnostic reagents and test kits.
Cepheid specializes in providing advanced diagnostic systems and supplies for infectious disease detection and clinical testing across multiple federal agencies, including the VA and Defense Logistics Agency. The company maintains substantial federal presence through two significant Indefinite Delivery Vehicle contracts with VA networks valued at over $35 million combined, reflecting its competitive positioning in federal molecular diagnostics procurement. The IHS BPA call supports the agency's laboratory and clinical testing operations, enabling continued access to Cepheid's GeneXpert diagnostic systems and associated reagent supplies for detecting conditions such as COVID-19, influenza, respiratory syncytial virus, and other infectious diseases critical to Indian Health Service clinical operations.
Quick answers
Who was awarded contract 75H71223F28005?
75H71223F28005 was awarded to Cepheid by Indian Health Service (Department of Health and Human Services) on February 8, 2023.
How much is contract 75H71223F28005 worth?
The government has obligated $187,000 on 75H71223F28005.
Is contract 75H71223F28005 an order under another contract?
Yes. 75H71223F28005 is a BPA call under 75H71223A00001, a blanket purchase agreement.
Was contract 75H71223F28005 competed?
The extent of competition for 75H71223F28005 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award